Nutex Health Inc.

For the period ended Dec 31, 2025. Filed Mar 5, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 5, 2026

NUTX$194.16+7.5%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Equity

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

Common Stock · Additional Paid-inCapital · Retained Earnings (Accumulated Deficit) · NoncontrollingInterests · TotalEquity
(In thousands, except share data) · Shares · Amount
Balance at January 1, 2023	4,334,825	$4		$459,144		$(363,286)		$24,465		$120,327
Deconsolidation of Real Estate Entities	—		—		—		—		(4,258)		(4,258)
Common stock issued for exercise of warrants	8,456	—		—		—		—		—
Common stock issued to Apollo Medical Holding Inc.	6,667	—		1,900		—		—		1,900
Common stock issued for Employee Stock Purchase Plan	515	—		14		—		—		14
Common stock issued for acquisition	16,943	—		906		—		—		906
Debt conversion to common stock	142,384	1		6,217		—		—		6,218
Stock-based compensation	1,409	—		936		—		—		936
Warrants issued with convertible debt	—		—		1,404		—		—		1,404
Contributions	—		—		—		—		298		298
Distributions	—		—		—		—		(5,215)		(5,215)
Net income (loss)	—		—		—		(45,787)		2,363		(43,424)
Balance at December 31, 2023	4,511,199	$5		$470,521		$(409,073)		$17,653		$79,106
Common stock issuance for Securities Purchase Agreement	444,444	—		1,540		—		—		1,540
Warrant exercises	444,445	1		11,643		—		—		11,644
Common stock received in sale of business	(5,060)	—		(30)		—		—		(30)
Common stock issued for Employee Stock Purchase Plan	8,405	—		86		—		—		86
Common stock issued for acquisition	64,746	—		406		—		—		406
Debt conversion to common stock	11,824	—		321		—		—		321
Vesting of Restricted Stock Units	1,298	—		—		—		—		—
Reverse stock split adjustment	3,116	—		—		—		—		—
Stock-based compensation	27,035	—		199		—		—		199
Contributions	—		—		4,723		—		2,170		6,893
Distributions	—		—		—		—		(6,438)		(6,438)
Net income	—		—		—		52,097		42,709		94,806
Balance at December 31,2024	5,511,452	$6		$489,409		$(356,976)		$56,094		$188,533

(Continued)

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

Common Stock · Additional Paid-inCapital · Accumulated Deficit · NoncontrollingInterests · TotalEquity
(In thousands, except share data) · Shares · Amount
Balance at December 31, 2024	5,511,452	$6		$489,409		$(356,976)		$56,094	$188,533
Warrant exercises	40,387	—	—		—		—	—
Common stock issued for Employee Stock Purchase Plan	3,502	—	263		—		—	263
Common stock issued for acquisition	2,102	—	250		—		—	250
Asset acquisition noncontrolling interest	—	—	—		—		1,989	1,989
Debt conversion to common stock	183,404	—	5,444		—		—	5,444
Vesting of Restricted Stock Units	38,867	—	—		—		—	—
Stock-based compensation	1,334,826	1	125,062		—		—	125,063
Stock repurchases and retirements	(27,870)	—	(4,953)		—		—	(4,953)
Contributions	—	—	152		—		615	767
Distributions	—	—	—		—		(74,276)	(74,276)
Net income	—	—	—		70,789		109,568	180,357
Balance at December 31, 2025	7,086,670	$7		$615,627		$(286,187)		$93,990	$423,437

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.